Literature DB >> 30710305

Serum S100B Levels in Melanoma.

Anna Lisa Frauchiger1, Reinhard Dummer1, Joanna Mangana2.   

Abstract

Malignant melanoma is a cancer with increasing incidence worldwide with relevant socioeconomic impact. Despite progress in prevention and early detection, it is one of the most lethal forms of skin cancer. Therefore it is urgent need to identify suitable biomarkers in order to improve early diagnosis, precise staging, and prognosis, as well as for therapy selection and monitoring. In this book chapter, we are focusing on S100B and discuss its clinical relevance in melanoma.

Entities:  

Keywords:  Calcium; EF hand; Follow-up; Melanoma; S100B; Staging; Therapy monitoring

Mesh:

Substances:

Year:  2019        PMID: 30710305     DOI: 10.1007/978-1-4939-9030-6_43

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Friend or Foe: S100 Proteins in Cancer.

Authors:  Chantal Allgöwer; Anna-Laura Kretz; Silvia von Karstedt; Mathias Wittau; Doris Henne-Bruns; Johannes Lemke
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

2.  Computational Design of Macrocyclic Binders of S100B(ββ): Novel Peptide Theranostics.

Authors:  Srinivasaraghavan Kannan; Pietro G A Aronica; Thanh Binh Nguyen; Jianguo Li; Chandra S Verma
Journal:  Molecules       Date:  2021-01-30       Impact factor: 4.411

3.  Biomarkers of tumor invasiveness in proteomics (Review).

Authors:  Daniel L Pouliquen; Alice Boissard; Olivier Coqueret; Catherine Guette
Journal:  Int J Oncol       Date:  2020-05-28       Impact factor: 5.650

4.  Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis.

Authors:  Eszter Anna Janka; Tünde Várvölgyi; Zoltán Sipos; Alexandra Soós; Péter Hegyi; Szabolcs Kiss; Fanni Dembrovszky; Dezső Csupor; Patrik Kéringer; Dániel Pécsi; Margit Solymár; Gabriella Emri
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.